Podocyte injury plays a vital role in focal segmental glomerulosclerosis (FSGS), and apoptosis is one of its mechanisms. The transient receptor potential channel 6 (TRPC6) is highly expressed in podocytes and mutations mediate podocyte injury. We found TRPC6 gene mutation (N110S) was a new mutation and pathogenic in the preliminary clinical work. The purpose of this study was to investigate the potential mechanism of mutation in TRPC6 (TRPC6-N110S) in the knock-in gene mouse model and in immortalized mouse podocytes (MPC5). Transmission electron microscopy was used to evaluate renal injury morphology. We measured 24-hour urinary albumin-to-creatinine ratios and major biochemical parameters such as serum albumin, urea nitrogen, and total cholesterol. The results of CCK-8 assay and apoptosis experiments showed that the TRPC6-N110S overexpression group had slower proliferative activity and increased apoptosis than the control group. FluO-3 assay revealed increased calcium influx in the TRPC6-N110S overexpression group. Podocin level was decreased in TRPC6-N110S group, while TRPC6 and desmin levels were increased in TRPC6-N110S group. The 24 h uACR at 6 weeks was significantly higher in the pure-zygotes group than in the WT and heterozygotes groups, and this difference was found at 8 and 10 weeks.TRPC6 levels showed no significant difference between homozygote and WT mice. Compared to homozygote group, expression of podocin and nephrin were increased in WT, but levels of desmin was decreased in WT. Our results suggest that this new mutation causes podocyte injury probably by enhancing calcium influx and podocyte apoptosis, accompanied by increased proteinuria and decreased expression of nephrin and podocin.
Bronchopulmonary dysplasia (BPD) is the most common chronic lung disease in preterm infants and is characterized by aberrant late-stage lung development driven by multiple factors. Although previous studies have demonstrated that BPD is associated with prenatal and postnatal inflammatory stimuli, the inflammatory mechanisms involved immune cell populations have not been fully elucidated. Here, we systematically investigated the roles of myeloid cells in the inflammatory processes underlying BPD. Using single-cell transcriptomic data of normal and BPD mouse lung, we found that the proportions of several myeloid subpopulations were specifically upregulated in BPD lung, including CCR1 + monocytes, CD74 + macrophages, IL7R + macrophages, MARCO + macrophages, CD63 + neutrophils, and CD73 + neutrophils. However, we only validated the increased proportions of CCR1 + monocytes in human BPD blood through flow cytometry analysis. Combined with bulk transcriptome and detection in serum of human BPD blood, we identified S100A8 and MMP8 as highly expressed downstream factors of CCR1 + monocytes. Immunofluorescence staining further confirmed the presence of CCR1 + monocytes expressing S100A8 or MMP8 in the mouse BPD lung tissues and demonstrated their association with disease development. Finally, in CCR1 + monocytes isolated from the peripheral blood of BPD infants, we found that the NF-κB and AKT pathways regulate the production of S100A8 and MMP8 respectively. Our study explored the role and mechanism of CCR1 + monocytes associated with BPD, which offers valuable insights for the development of novel clinical biomarkers and therapeutic strategies for BPD.